Altunate Pharma Private Limited

Founded in 2020 and headquartered in Telangana, India.

2020 | Hyderabad, Telangana (India) | Active
Last Updated: December 29, 2024

Altunate Pharma Profile

Key Indicators

  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 1 Month
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth %
  • Profit Growth 128.48%
  • Ebitda 128.48%
  • Net Worth 20.39%
  • Total Assets 5327.21%

About Altunate Pharma

Altunate Pharma Private Limited (APPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 20 January 2020 (Five years and one month 6 days old ). Its registered office is in Hyderabad, Telangana, India.

The Company is engaged in the Chemicals Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.

Navya Bashetti and Vijaya Dammk serve as directors at the Company.

Company Details

  • Location

    Hyderabad, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24232TG2020PTC138530

  • Company No.

    138530

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    20 Jan 2020

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Chemicals
Pharmaceuticals

Who are the key members and board of directors at Altunate Pharma?

Board Members (2)

NameDesignationAppointment DateStatus
Navya Bashetti Country flag representing In Director 20-Jan-2020Current
Vijaya Dammk Country flag representing In Director 20-Jan-2020Current

Financial Performance of Altunate Pharma.

Altunate Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 128.48% increase in profit. The company's net worth Soared by an impressive increase of 20.39%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
5327.21%
Profit or Loss
128.48%
Net Worth
20.39%
EBITDA
128.48%

What is the Ownership and Shareholding Structure of Altunate Pharma?

Unlock access to Altunate Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Altunate Pharma?

Unlock and access historical data on people associated with Altunate Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Altunate Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Altunate Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Altunate Pharma

Recent activity within the organization

  • Annual General Meeting

    Altunate Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    Altunate Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.

    31 Mar 2024

  • Director Appointment

    Navya Bashetti was appointed as a Director was appointed as a Director on 20 Jan 2020 & has been associated with this company since 5 years 1 month .

    20 Jan 2020

  • Director Appointment

    Vijaya Radhika Dammk was appointed as a Director was appointed as a Director on 20 Jan 2020 & has been associated with this company since 5 years 1 month .

    20 Jan 2020

  • Company Incorporation

    Altunate Pharma Private Limited was registered on 20 Jan 2020 with Roc Hyderabad & aged 5 years 1 month as per MCA records.

    20 Jan 2020

Frequently asked questions

  • Altunate Pharma Private Limited was incorporated on 20 Jan 2020.

  • The authorized share capital of Altunate Pharma Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.

  • Currently 2 directors are associated with Altunate Pharma Private Limited.

    • Navya Bashetti
    • Vijaya Radhika Dammk
  • As per Ministry of Corporate Affairs (Mca), the registered address of Altunate Pharma Private Limited is 6-148 Bhavani Ngr Santosh Nagar India, Hyderabad, Telangana, 500059.

  • The corporate identification number (CIN) of Altunate Pharma Private Limited is U24232TG2020PTC138530 and the company number is 138530 as per Ministry of Corporate Affairs (MCA).

  • The financial reports for the fiscal year 2022 indicates that The net worth of Altunate Pharma Private Limited has experienced an upsurge of 20.39%.

  • The most recent Balance Sheet for Altunate Pharma Private Limited was filed with the ROC on 31 Mar 2024.